October 2025
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
April 2026
The global automation, digitization and robotics in cell and gene therapy manufacturing market size was evaluated at USD 950.00 million in 2025 and is predicted to hit around USD 5,275.10 million by 2035, growing at a CAGR of 18.70%.
April 2026
The global cell and gene therapy market size was calculated at USD 8.94 billion in 2025 and is projected to surpass around USD 47.18 billion by 2035 with a solid CAGR of 18.1%.
August 2025
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%.
July 2025
The global cell and gene therapy CDMO market size is estimated to hit around USD 74.03 billion by 2034 increasing from USD 6.31 billion in 2024, with a CAGR of 27.92%.
July 2025
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 548.55 million in 2024, with a CAGR of 7.34%.
July 2025
The cell and gene therapy manufacturing market size is predicted to hit around USD 122.86 billion by 2034 from USD 11.60 billion in 2024, with a CAGR of 26.62%.
July 2025
The cell and gene therapy infrastructure market is expanding with scalable manufacturing, integrated delivery networks, and advanced clinical site readiness.
July 2025
Explore the cell and gene therapy patient access and reimbursement Market, driven by evolving payer policies, value-based care models, and rising adoption of high-cost cell and gene therapies.
January 2026
The global allogeneic cell therapy devices market size is projected to hit around USD 4,565.79 million by 2035 from USD 511.30 million in 2025 with a CAGR of 24.48%.
May 2026
The global automated and closed cell therapy market size is estimated to hit around USD 12.9 billion by 2035 increasing from USD 1.86 billion in 2025, with a CAGR of 21.37%.
December 2025
The global cell and gene supply chain services market size is expected to hit over USD 4.65 billion by 2035 from USD 1.75 billion in 2025, with CAGR of 10.27%.
December 2025
The global automated and closed cell therapy processing system market size is expected to hit around USD 14.46 billion by 2035 with a CAGR of 22.76%.
September 2025
The global autologous stem cell and non-stem cell based therapies market size is estimated to hit around USD 25.78 billion by 2034 increasing from USD 8.64 billion in 2024, with a CAGR of 11.55%.
May 2026
The global in vitro diagnostics quality controls market size is estimated to hit around USD 2,713.92 million by 2035, increasing from USD 1,736.17Â million in 2026, with a CAGR of 5.09%.
May 2026
The stem cell therapy market size is expected to increase from USD 18.13 billion in 2025 and it is predicted to hit USD 59.70 billion by 2035 at a CAGR of 12.66%.
May 2026
The global CAR T-cell therapy market size is calculated at USD 5,206.15 million in 2025 and is projected to surpass around USD 26,982.3 million by 2035 with a solid CAGR of 17.88%.
May 2026
The global cell therapy market size is valued at USD 7.43 billion in 2025 and is projected to hit around USD 55.52 billion by 2035 with a CAGR of 22.28%.
May 2026
The global gene-replacement therapy market analysis covers market size, growth drivers, key players, pipeline advances, and regulatory trends shaping future demand.
April 2026
The autologous cell therapy market size was garnered at USD 11.43 billion in 2025 and is expected to hit around USD 60.03 billion by 2035 With a CAGR of 18.04%.
April 2026
The cancer gene therapy market size was estimated at USD 4.14 billion in 2025 and is projected to hit around USD 22.32 billion by 2035 with a CAGR of 18.35%.
March 2026
The global air quality control system market size is expected to hit around USD 189.36 billion by 2035 from USD 116.16 Billion in 2025 with a CAGR of 5.01%
February 2026
The global T-cell therapy market size is reached at USD 10.30 billion in 2025 and it is expected to hit around USD 196.21 billion by 2035 with a CAGR of 34.27%.
November 2025
The global induced pluripotent stem cell (iPSC) therapy market is driven by rising chronic disease prevalence, personalized medicine demand, and advances in regenerative technology.
November 2025
The global gene therapy market size was exhibited at USD 11.07 billion in 2025 and is predicted to hit around USD 55.43 billion by 2034 with a solid CAGR of 19.60%.
November 2025
The global AAV gene therapy market size was evaluated at USD 2,853.36 million in 2025 and is predicted to hit around USD 23,546.27 million by 2034, with a CAGR of 26.43%.
October 2025
The U.S. stem cell therapy market size reached USD 6.75 billion in 2025 and is projected to hit around USD 21.31 billion by 2035 with a remarkeble CAGR of 12.55%.
October 2025
The global T-cell immunotherapy market size is estimated to hit around USD 26.53 billion by 2034 increasing from USD 8.43 billion in 2025, with a CAGR of 13.59%.
October 2025
The global oncolytic virus-based gene therapy market is growing rapidly as viral vectors are engineered to selectively target and destroy cancer cells.
October 2025
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com